Infection by Mycoplasma pneumoniae and its importance as an etiological agent in childhood community-acquired pneumonias
LA Vervloet, CMarguet… - Brazilian Journal of …, 2007 - SciELO Brasil
This manuscript reviewed the literature on infection by Mycoplasma pneumoniae with emphasis
on etiological aspects of childhood community-acquired pneumonias. Bibliographical …
on etiological aspects of childhood community-acquired pneumonias. Bibliographical …
Add-on omalizumab in children with severe allergic asthma: a 1-year real life survey
A Deschildre, CMarguet, J Salleron… - European …, 2013 - Eur Respiratory Soc
Omalizumab has been shown to reduce exacerbation rates in moderate to severe allergic
asthma. Our aim was to evaluate omalizumab efficacy and safety in a real-life setting in severe …
asthma. Our aim was to evaluate omalizumab efficacy and safety in a real-life setting in severe …
[HTML][HTML]In very young infants severity of acute bronchiolitis depends on carried viruses
CMarguet, M土著女人no, M Gueudin, P Le Roux… - Plos one, 2009 - journals.plos.org
Background RT amplification reaction has revealed that various single viruses or viral co-infections
caused acute bronchiolitis in infants, and RV appeared to have a growing …
caused acute bronchiolitis in infants, and RV appeared to have a growing …
Rapid improvement after starting elexacaftor–tezacaftor–ivacaftor in patients with cystic fibrosis and advanced pulmonary disease
…, A Prevotat, D Grenet, CMarguet… - American journal of …, 2021 - atsjournals.org
Rationale: Elexacaftor–tezacaftor–ivacaftor is a CFTR (cystic fibrosis [CF] transmembrane
conductance regulator) modulator combination, developed for patients with CF with at least …
conductance regulator) modulator combination, developed for patients with CF with at least …
Long-term outcome of idiopathic pulmonary hemosiderosis in children.
…, JC Desbois, G Bellon, J Derelle, G Dutau, CMarguet… - Medicine, 2000 - europepmc.org
We retrospectively analyzed the long-term outcome of idiopathic pulmonary hemosiderosis (IPH)
in 15 children. IPH started at a mean age of 5 years, and the mean duration of follow-up …
in 15 children. IPH started at a mean age of 5 years, and the mean duration of follow-up …
Real-life long-term omalizumab therapy in children with severe allergic asthma
A Deschildre, CMarguet,C Langlois… - European …, 2015 - Eur Respiratory Soc
We previously reported the French real-life experience of 1 year of add-on treatment with
omalizumab in 101 severe allergic asthmatic children (6–18 years), 92 of whom were still …
omalizumab in 101 severe allergic asthmatic children (6–18 years), 92 of whom were still …
[HTML][HTML]A national internet-linked based database for pediatric interstitial lung diseases: the French network
…,C Schweitzer, ML Dalphin, CMarguet… - Orphanet journal of rare …, 2012 - Springer
Background Interstitial lung diseases (ILDs) in children represent a heterogeneous group of
rare respiratory disorders that affect the lung parenchyma. After the launch of the French …
rare respiratory disorders that affect the lung parenchyma. After the launch of the French …
Real-life safety and effectiveness of lumacaftor–ivacaftor in patients with cystic fibrosis
…, M Porzio, M Abely, P Reix, CMarguet… - American Journal of …, 2020 - atsjournals.org
Rationale: Lumacaftor–ivacaftor is a CFTR (cystic fibrosis transmembrane conductance
regulator) modulator combination recently approved for patients with cystic fibrosis (CF) …
regulator) modulator combination recently approved for patients with cystic fibrosis (CF) …
Molecular and cellular characteristics ofABCA3mutations associated with diffuse parenchymal lung diseases in children
…, V Rigourd, F Brémont, CMarguet… - Human molecular …, 2012 - academic.oup.com
ABCA3 (ATP-binding cassette subfamily A, member 3) is expressed in the lamellar bodies
of alveolar type II cells and is crucial to pulmonary surfactant storage and homeostasis. …
of alveolar type II cells and is crucial to pulmonary surfactant storage and homeostasis. …
Influence of Interleukin-10 onAspergillus fumigatusInfection in Patients with Cystic Fibrosis
…, B Delaisi, JF Duhamel, CMarguet… - The Journal of …, 2005 - academic.oup.com
Recent evidence suggests that genetic polymorphisms that affect the production of interleukin
(IL)–10 may play a role in the response to pathogens in cystic fibrosis (CF). The present …
(IL)–10 may play a role in the response to pathogens in cystic fibrosis (CF). The present …